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Complaints against doctors
Could be reduced by identifying and remedying poor communication skills early on
Clinical communication skills are at the heart of medical 
practice, and poor performance is an important factor in 
the origins of complaints and litigation.1  2 A recent study 
from Canada shows that poorly performing doctors can 
be identified early in their careers and possibly given 
targeted support and appropriate further training.3 
Tamblyn and colleagues followed up a cohort of newly 
qualified doctors in Ontario and Quebec for two to 12 
years.3 They found a link between both communication 
and quality of care scores on the clinical skills examina-
tion of the Medical Council of Canada (taken shortly 
after graduation) and subsequent complaints registered 
with the medical regulatory authorities. A decrease of 
two standard deviations in communication score on the 
examination was associated with one additional com-
plaint per 100 years of practice. People whose scores of 
communication skills were in the bottom quartile had 
a significantly increased risk of subsequent complaints 
from patients (excess complaint rate 2.15 per 100 prac-
tice years compared with the three other quartiles).
Although the rate of complaints per 100 years might 
seem low, complaints were made against 17% of doctors 
at least once during the average 10 year follow-up period. 
Factors that were significantly associated with increased 
numbers of complaints were the clinician being male 
and working in family practice or surgery (rather than 
general medicine). Most of these doctors would have 
received training in communication skills during their 
medical school training, although this may have been of 
variable quality, and they were well aware of the content 
of the clinical skills examination.
Considerable resources are currently devoted to teach-
ing and assessing the communication skills of medical 
students. The Calgary Cambridge guide is well estab-
lished as a generic guide to consultations and the skills 
needed for effective communication.4 Students are often 
tested for communication skills—for example, taking a 
history; exploring the patient’s perspective, concerns, 
and expectations; explaining diagnoses and treatment; 
and discussing options for treatment or care. Students 
also cover specific tasks such as breaking bad news.
Tamblyn and colleagues’ results suggest that  doctors 
whose communication skills need to be improved 
could be identified before problems are encountered 
in clinical practice. Stricter thresholds for passing 
 graduate  medical examinations or postgraduate quali-
fications could be enforced. However, as these research-
ers point out, the reliability of many  assessments of 
 communication skills is low (and lower than assessments 
of clinical skills, for example), especially if  relatively few 
(four or five)  objective structured clinical examination 
stations are used.
More could be done with the data already being col-
lected during medical training. Firstly, examinations 
commonly test a range of knowledge, skills, and attitudes 
to produce an overall mark, and poor performance in 
one area can often be compensated for by good perform-
ance in another. To combat this we may need to make 
examinations more modular and make it mandatory for 
students to pass the communication skills component. 
Secondly, more could be done with data from examina-
tions. Students who only just pass or who fail at their 
first attempt and pass subsequently are at high risk of 
complaints in the future. Proactive efforts may be able 
to rectify their deficiencies and reduce the risk of subse-
quent poor performance or complaints.
The assessment of doctors already in practice presents 
greater challenges.5 Both individual and contextual fac-
tors must be considered, with a clear focus on how the 
clinician is functioning at work. Four frames of assess-
ment of competence are described—performance in 
assessments before practice; participation in continuing 
medical education and training programmes; perform-
ance in work processes such as review of medical records 
and peer appraisal; and assessment of outcomes of work, 
which should include complaints and litigation.5
How the doctor functions within the team is also 
important. Three levels of assessing performance have 
been described—screening of entire populations or ran-
dom samples thought to be at low risk; targeting of those 
thought to be at risk (for example, doctors who are pro-
fessionally isolated); and assessing those about whom 
there are specific concerns.6 These assessments could 
be used to scrutinise the performance of doctors on a 
regular basis after completing postgraduate training.
Providing support to poorly performing doctors is as 
complex as the methods of assessment, and it is difficult 
to achieve improvements. A systematic review found 
that only two of seven trials of interventions to enhance 
patient centred behaviour improved patients’ assess-
ments of interpersonal care skills.7 Experienced clinicians 
may have developed ingrained patterns of behaviour. 
Lack of insight may prevent doctors from remedying 
their weaknesses, even when they are accurately identi-
fied.8 Additional training in communication skills can be 
provided, however, and it may benefit some groups.
Poor communication that triggers complaints may 
indicate global deficits rather than a simple lack of skill 
in talking to patients, and it may be an indicator of 
poor health, poor decision making, or other  cognitive 
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problems. Depression and burnout are common in jun-
ior doctors. They greatly affect performance and may 
reflect the influences of the organisation and deficiencies 
in service delivery as much as individual problems.9 A 
package of intervention and continuing support through 
 remediation and reassessment is often needed. A range of 
services has been set up to help struggling doctors. These 
services often consider the individual’s health and social 
and personal problems.10-12 The goals include improv-
ing clinician performance—particularly with regard to 
 communication skills—as a way to reduce  complaints and 
other malpractice outcomes, but more importantly to 
help the clinician become an effective and safe  deliverer 
of health care. Evidence on the  effectiveness of such 
interventions is still needed, but they are essential com-
ponents of our educational programmes.
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Surgical treatment of pilonidal disease
off-midline sutures improve outcomes compared with midline sutures
In the accompanying paper, McCallum and colleagues 
report a systematic review of the effects of different 
surgical techniques for treating pilonidal sinus.1 Piloni-
dal disease is an infection in a “ditch” that results from 
mechanical stretch, which causes enlargement and rup-
ture of hair follicles in the natal cleft.2 The disease is 
confined to skin and fat, can be acute or chronic, minor 
or major, and can range from an asymptomatic pinhole 
in skin to an abscess the size of an orange.
The disease affects mainly young men aged 15-
30. McCallum and colleagues report an incidence of 
26/100 000,1 but it varies by population—from 0.11% 
in women at college to 8.8% in Turkish soldiers. One 
large series reported that 78 924 US servicemen in the 
second world war were in hospital for an average of 55 
days each with pilonidal problems, chiefly because of 
complications of wide excision.3 As a result, wide exci-
sion was banned by the surgeon general—a ban that was 
subsequently ignored. Pilonidal disease is often treated 
by removing the diseased skin and subcutaneous tissue 
completely. The surgical wound is either closed with 
sutures (for healing by primary intention) or packed 
open (to heal by second intention). Both treatments can 
lead to recurrences and unhealed wounds,3 4 so many 
clinical trials have compared whether it is better to pack 
the wound open or to close it.5
McCallum and colleagues’ study is a systematic 
review of such trials. It assesses the effects of open heal-
ing versus closed surgical treatment and the optimal 
method of closure (midline versus off-midline) for pilo-
nidal sinus. The outcomes were time to healing, surgical 
site infection, and recurrence rate.1 The review found no 
significant difference between open and closed healing 
in the rates of surgical site infection, and recurrence was 
significantly less likely after open healing (relative risk 
0.42, 95% confidence interval 0.26 to 0.66). Data were 
insufficient to make conclusions about time to wound 
healing. Compared with off-midline surgical closure, 
midline closure significantly increased healing time, 
recurrence, and infection of the surgical site.1 
The authors conclude that based on current evidence, 
off-midline closure should become standard manage-
ment of pilonidal sinus.1 The saying, “stay out of the 
ditch,” repeats the sense of their words, and these con-
clusions are supported by other reports.2  6
However, the review does not explore the more 
fundamental question of whether extensive excision is 
even necessary. The included trials analysed different 
methods of excising diseased tissue, but these methods 
were developed before our current understanding of 
pilonidal disease.
Two options are available for the treatment of piloni-
dal disease. Surgeons can remove tissue thickened by 
bacterial invasion or reshape the contours that fostered 
that invasion.6 Widely removing a pilonidal abscess 
treats pilonidal disease as if it were a malignancy. 
Reshaping it treats it as an infection, with the guiding 
principles being to drain abscesses and protect tissue 
from bacteria.7  8
So what should be considered best practice for the 
treatment of pilonidal sinus? For early primary disease 
collected hair and keratin can simply be removed from 
the pits of origin.9 In my opinion, Armstrong and Barcia 
describe this conservative management well and estab-
lish its desirable results,9 although they did not conduct a 
double-blind study to prove that their approach is supe-
rior to all other approaches to early primary pilonidal 
disease. For more advanced primary disease the tiny 
midline pits of origin can be excised and the abscess 
cavities cleaned out through off-midline incisions.2 For 
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Intergenerational recurrence of breech delivery
maternal and paternal history of breech increase risk equally
advanced disease involving deep clefts, multiple sinus 
tracts, and failure of previous surgery, the depth of the 
cleft should be reduced and use made of flaps and off-
midline closure of the wound.1  8
Patients and clinicians can access the principles of 
off-midline care through a website operated by the Pilo-
nidal Support Foundation (www.pilonidal.org/). The site 
maintains a fully accessible registry of surgeons familiar 
with off-midline repairs, which lists 58 surgeons world-
wide including eight in the United Kingdom. As with 
laparoscopic gallbladder surgery, patients may become 
advocates of off-midline closure.
Future research should try to define why midline 
wounds are problematic. Is it unusual bacteria, low 
ambient oxygen in the cleft, or high pressures that trap 
pus? The surgical community is a tough nut to crack, but 
hopefully surgeons will take up these improved methods 
in the years to come. After all, it took nearly a century 
for the disproved theory of the congenital origin of pilo-
nidal sinuses to die out. 
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Much attention has been focused on the consequences 
of breech presentation and on strategies to minimise 
risk for both the fetus and the mother. Studies, includ-
ing the landmark term breech trial, have had a posi-
tive effect on clinical practice and set a standard in 
developed countries of caesarean delivery for persist-
ing breech presentation.1-3 Less attention, however, has 
been focused on why some fetuses deliver in breech 
position. In the accompanying paper, Nordtveit and 
colleagues investigate whether the risk of breech deliv-
ery can be passed on through generations via both men 
and women.4
The prevalence of breech presentation decreases 
through gestation as fetuses mature, and most fetuses 
move into cephalic position before delivery. The preva-
lence of breech presentation is 25% at 28 weeks’ gesta-
tion and 3-4% at term.5 Risk factors include maternal 
characteristics (primiparity, contracted pelvis, high 
maternal age, and uterine abnormality); characteris-
tics of the pregnancy (multifetal gestation and placen-
tal implantation site); and fetal factors (preterm birth, 
growth retardation, neuromuscular dysfunction, and 
malformations).6-10
The high recurrence of breech presentation between 
siblings may largely be attributable to the maternal uter-
ine environment.11 However, recurrence between gen-
erations suggests that one or more genetic factors may be 
passed from the parent to the developing fetus. Nordtveit 
and colleagues investigated this possibility by using the 
medical birth registry of Norway.4 This registry is a popu-
lation based compulsory registry of all live births and still 
births of 16 weeks’ or more gestation.4 It contains the 
records of more than 2 million births in Norway since 
1967 and is a respected resource for medical and public 
health research.
Using registry data, the authors linked mothers’ and 
fathers’ birth records (1967-86) to the records of their 
offspring (1987-2004). First born singleton offspring with 
a birth weight of 500 g or more and their parents were 
included in the study. To investigate paternal effects, 
paternal half sibling births were also examined. The 
authors evaluated multiple factors in the parental histo-
ries in relation to breech delivery in the offspring.
The authors’ main conclusion was that an increased 
risk of breech delivery in first born offspring was asso-
ciated with both a maternal and a paternal history of 
breech delivery at term. The paternal effect was as strong 
as the maternal effect (odds ratio maternal 2.2, 95% confi-
dence interval 1.9 to 2.5; paternal 2.2, 1.8 to 2.7).4 These 
findings are novel and intriguing, but are they robust?
Overall, the authors’ results seem plausible. However, 
further discussion of missing data, possibly  inaccurate 
or inconsistently recorded data, and of potential 
 misclassification would have been helpful. For exam-
ple, an improved data collection tool with a checkbox 
for breech delivery was introduced in 1999, and breech 
delivery may have been misclassified in both parents and 
offspring before this date. It would have been informa-
tive to discuss how this could have influenced the results, 
especially as the prevalence of breech presentation 
increased over the study period. 
Interestingly, some of their results on maternal and 
paternal birth order might suggest less of a genetic trait 
for breech presentation than an environmental factor or 
interaction. A breech trait is unlikely to be preferentially 
passed to offspring from first born rather than second 
born parents. Future research looking at the offspring’s 
uterine environment and specific characteristics (for 
example, specific major malformations) in the context 
of parental birth factors may provide some insight into 
the authors’ reported maternal and paternal effects.
Members of Nordtveit’s team have published other arti-
cles on breech presentation and have used the  Norwegian 
registry for generating and testing  hypotheses.4 10 12 These 
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 institutions for resources to motivate the people 
within them, even doctors.
This conclusion is hardly new as it has guided NHS 
policy since the early 1990s, except for an interlude 
between 1997 and 2001. For some, it is flatly unac-
ceptable on grounds of ideology or plain self interest, 
but for others—in the United Kingdom and interna-
tionally—the question is not whether incentives such 
as competition have a role but what is the right blend 
of them to achieve an effective efficient, responsive, 
and equitable health system. This question is squarely 
on the plate of Lord Darzi in his major review of NHS 
policy, which reports this June. His team is focusing 
on three broad areas: what world class quality of care 
looks like in a range of clinical areas; enablers and 
barriers to achieving world class care such as lead-
ership and workforce; and “other,” which includes 
work on informatics, examining the case for an NHS 
constitution, and looking at “system incentives.” It 
is this last area that is key to success or failure of 
the review, not the construction of more up to date 
evidence based clinical pathways (important though 
these are).
The slate is clearly not blank. The set of reforms 
designed by the Blairites to increase competition and 
choice, and enhance regulation, is still under construc-
tion and barely implemented. The record so far of the 
recent reforms is mixed and weak. Payment by results 
is not having as much effect as hoped.4 Practice based 
In 2002, a bitter argument raged in the letters pages 
of the BMJ. It followed the publication of a study 
by Feachem and colleagues comparing an American 
managed care organisation, Kaiser Permanente (North 
California), and the NHS.1 The NHS fared less well 
on several indicators of effectiveness and efficiency of 
care. Feachem and colleagues (and others) concluded 
that a combination of competition, better informa-
tion systems, and other incentives—not just level of 
funding—explained Kaiser’s better performance.1 The 
study was quickly attacked on methodological and 
ideological grounds.2
Intrigued like many others, a group at the King’s 
Fund looked more closely at the care provided for 
people with long term conditions at Kaiser and four 
other top performing managed care organisations 
in the United States. We found systematic highly 
proactive and personalised care—nothing in theory 
that could not be provided in the NHS, although 
it frequently is not. Our conclusion was that the 
Department of Health should focus as much on the 
“how” of care (how to motivate institutions to pro-
vide good quality care)—as much as the “what” (what 
good quality care looks like).3 Incentives are crucially 
important. The non-financial incentives arising from 
professionalism and peer review, central directive, 
regulation and public reporting of performance, and 
local accountability are not enough; and more con-
troversially, there is a role for competition between 
844   BMJ | 19 april 2008 | VoluMe 336
and other observational studies that use large linked 
population databases, such as the medical birth registry 
of Norway, are of value and are especially useful for 
research questions that need large study samples. Mul-
tiple biological mechanisms probably contribute to the 
risk of breech presentation—some genetic (maternal or 
paternal, or both), some related to the uterine environ-
ment, and some a combination of both. Nordtveit and 
colleagues’ findings are novel, but strength of evidence 
will come from consistent conclusions across multiple 
epidemiological and laboratory investigations.
So what should clinicians do in the meantime? It is 
premature to advise mothers of a higher risk of a breech 
delivery if their parents had a breech delivery. However, 
clinicians should continue to gather information during 
early prenatal care on maternal and paternal birth presen-
tation and other potential risk factors for breech delivery. 
This combined information may serve to alert the clini-
cian and patient to the possibility of breech presentation 
and that they should discuss planned external cephalic 
version or caesarean section delivery (or both).
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commissioning is not exciting enough interest among 
general practitioners to make it work.5 Primary care 
trust commissioning seems to be as weak as the health 
authority commissioning before it. The independent 
sector has been used with good effect to help drive 
down waiting times and provide choice,6 but with 
some avoidable and perverse local effects mainly 
because of the nature of the “take or pay” contracts 
initially signed with the Department of Health.7 And 
the extent to which patients are exercising choice is 
not clear.
Yet the studies cited above show that many impor-
tant incentives are now in place that are helping 
to increase the quality and efficiency of care for 
patients. NHS trusts, under payment by results and 
patient choice, have improved efficiency.4-8 Primary 
care trusts and practice based commissioners are 
improving out of hospital care and reducing avoid-
able admissions,4 and the threat of competition 
from non-NHS providers is galvanising efforts by 
NHS trusts to improve quality, although evidence 
is as yet anecdotal.7 Payment by results, foundation 
 status, and practice based commissioning are leading 
to increased scrutiny of data on efficiency.8 9 Better 
data on costs are prompting demand for better data 
on outcomes.
It would be tempting for Darzi to steer clear of 
this difficult and controversial area, but he should 
make it his central theme. It is important to recog-
nise that the current incentives are along the right 
lines but amendments are needed. High on his prior-
ity list should be reducing perverse local effects of 
some of the existing financial incentives (for example, 
payment by results rewards hospitals for increasing 
admissions but it rewards primary care trusts and 
practice based commissioners for reducing them), 
breathing life into practice based commissioning by 
at least ensuring practices are given accurate budgets 
covering a year in advance, and encouraging seri-
ous competition on outcomes. Darzi should focus on 
incentives to institutions, not to teams or individuals 
within them. The ability of the Department of Health 
to craft detailed financial incentives effectively for 
individuals is shown by the huge cost relative to the 
opaque benefits of the contracts for consultants and 
general practitioners.10  11 
Leave it local
More controversial decisions, such as the extent to 
which integrated care could be progressed through joint 
management of a capitated budget by hospitals and 
practices,12 the extent that competition for resources 
between providers should be enhanced, or whether 
individualised budgets should be given to patients 
could be the subject of a set of carefully crafted pilots 
evaluated “in real time” (not three years after the event) 
genuinely to inform ongoing policy on incentives. It is 
not possible to settle ideological disputes about the role 
of competition or other incentives using evidence, but 
it helps, and there is no excuse for not improving the 
evidence base to policy making.
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Deaths in custody
the risk factors are known, but public policy is lagging behind
The excess risk of death for offenders is a public 
health concern. International comparisons of deaths in 
penal institutions published by the Council of Europe 
show wide variability in rates of overall mortality and 
 suicide, sentencing policy, and rates of  incarceration 
between countries.1 However, rates of suicide are 
 significantly higher in prison  populations than in 
free  living  populations worldwide.2-5 These findings 
 suggest that referral to prison may not be appropriate 
for some people and identify gaps in knowledge for 
healthcare professionals and policy makers.
The recent increase in suicide (registered as self 
inflicted death) rates in prisoners in England and 
Wales comes against a background of a steady and 
downward trend since the turn of the century (table), 
despite increases in the prison population from around 
60 000 in the late 1990s to just over 80 000 by the end 
of 2007. Deaths from natural causes have risen during 
this period and at 11.3 per 10 000 have now reached 
the level seen for self inflicted death.
Alison Frater consultant in public 
health, Public Health sciences 
and medical statistics (PHsms), 
University of southampton, 
southampton General Hospital, 
southampton so16 6YD 
alison.frater@btinternet.com
BMJ 2008;336:845-6
doi:10.1136/bmj.39546.635729.80
 
BMJ | 19 april 2008 | VoluMe 336       845
EDITORIALS
Routine statistics are not collected on prisoners after 
release, but studies have found that the risk of death is 
three to five times higher in adult men recently released 
from custody, compared with the normal population, 
and even higher for younger age groups.6  7
Large scale studies of deaths in custody and national 
commissions of enquiry point to some of the causes 
of this high risk of death among offenders.4 5 8 Some 
excess deaths, both during and immediately after 
custody, are caused by addiction to drugs or alcohol. 
More timely intervention by drug and alcohol reha-
bilitation services is needed, as are better facilities to 
prevent overdoses, particularly overdose arising from 
reduced resistance to toxicity on release.3 People with 
serious mental illness—who account for about 6-25% of 
the prison population—are especially vulnerable, and 
alternatives to prison are needed.2-4
Problems arise when prison staff misinterpret the 
behaviour of offenders with psychiatric problems or 
physical illness. Epileptic seizures have been inter-
preted as resisting restraint and diabetic ketoacidosis 
has been mistaken for drunkenness or “acting up.”3 8 
Studies often highlight lack of training in resuscitation,4  8 
and improved training overall could help reduce deaths 
from suicide and from natural causes.
Comparative studies have thrown light on the com-
plex reasons for suicide in prison. Preventive strategies 
should be tailored to meet the needs of individuals, 
particularly with respect to characteristics identified 
before imprisonment, such as drug use and mental 
illness.9 Most studies comment on the importance of 
better access to psychological support for people at risk 
of suicide and for preventive strategies in the wider 
prison environment, such as safer cell design, removal 
of ligature points, and improved access to meaningful 
activity and support networks. Clear evidence points 
to the vulnerability of younger people to the risk of 
suicide, and on the importance of measures to pre-
vent suicide during the period immediately after being 
taken into custody.4 5 10
So what needs to be done? An integrated cross gov-
ernmental strategy between prison authorities, health 
services, and other agencies is needed.11 Preventive 
strategies based on the dynamics of prison suicide have 
been introduced. These include a more progressive drug 
policy, improvements in the reception and first night 
process, access to the Samaritans and trained listen-
ers, and increased monitoring of prisoners through the 
“assessment, care in custody, and teamwork” system.
Factors affecting premature death from natural 
causes are being investigated. The prison and pro-
bation ombudsman reviews all deaths in prison, 
although to date detailed scrutiny through methods 
such as confidential enquiry has been confined to 
suicides and homicides. The coroner’s office and 
voluntary sector organisations have highlighted 
failures in care in individual cases. The recently 
established forum for preventing deaths in custody 
is pressing the government to introduce powers to 
make public bodies act on the recommendations of 
coroner’s reports.12
The transfer of responsibility for medical care 
in prison to the NHS was widely expected to raise 
standards of health care by improving accountabil-
ity and transparency,11 although private prisons are 
still allowed to provide care directly. Primary care in 
prisons is still in the early stages of development and 
differs in several important ways to that available in 
the community. General practitioners are contracted 
only on a sessional basis, prisoners are not registered 
with them, prison populations are not yet included in 
the quality and outcomes framework, and advocacy 
is limited.
Further research will provide data to refine deci-
sions about the appropriateness of interventions and 
best practice. However, this is currently limited by 
the lack of routine information across the prison sys-
tem and record linkage into the community. Prisons 
are not currently linked by a national database, no 
routine national surveys look at the health of prison-
ers, and few properly conducted studies have evalu-
ated the effectiveness of control measures. Estimates 
of relative mortality have been published, but more 
precise measures of the effect of exposure to prison 
and its consequences are needed.2 4 5
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Self inflicted deaths (rate per 10 000 prisoners)* 
Financial year Rate
2001/2 11.1
2002/3 14.8
2003/4 12.6
2004/5 11.3
2005/6 9.6
2006/7 9.5
2007/8 11.1
*Personal communication (M Keane, 2008)
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